Grants

NU21-08-00237: Advanced sequencing methods for deciphering structural variants in the cancer genome
Czech Health Research Council, Ministry of Health, CZE, 2021-2024.
Principal investigator: Karla Plevová (under CEITEC MU).

19-11299S: The role of transposable element activity in hematological malignancies
Czech Science Foundation, 2019-2021.
Principal investigator: Karla Plevová (under University Hospital Brno).

TJ02000133: Development of modular bioinformatics platform for next-generation sequencing data analysis
Technology Agency of the Czech Republic (TACR), Program Zeta, 2019-2021.
Principal investigator: Tomáš Reigl (under CEITEC MU). Evaluation: A.

15-31834A: Selection of genomic defects in chronic lymphocytic leukemia and their impact on disease outcome
Czech Health Research Council, Ministry of Health, CZE, 2015–2018.
Principal investigator: Šárka Pospíšilová (CEITEC MU)
Co-principal investigator: Karla Plevová (under University Hospital Brno). Evaluation: A.

15-30015A: Analysis of clonal heterogeneity in chronic lymphocytic leukemia using next-generation sequencing of B cell receptor. A national study
Czech Health Research Council, Ministry of Health, CZE, 2015–2018.
Principal investigator: Michael Doubek (under University Hospital Brno). Evaluation: A.